Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
British Journal of Pharmacology|May 16, 2002
[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptorGirolamo Calo, Anna Rizzi, Daniela Rizzi, et al.
Palliative & Supportive Care|June 22, 2016
Parents with cancer: Searching for the right balance between telling the truth and protecting childrenFausto Meriggi, Federica Andreis, Nadia Liborio, et al.
European Journal of Pharmacology|November 23, 2016
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13)Maria Camilla Cerlesi, Huiping Ding, Mark F Bird, et al.
The Journal of Biological Chemistry|May 25, 2006
Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activationAdelheid L Roth, Erika Marzola, Anna Rizzi, et al.
Peptides|February 23, 2010
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68Chiara Ruzza, Anna Rizzi, Claudio Trapella, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 3, 2007
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studiesBarbara Spagnolo, Giacomo Carrà, Martina Fantin, et al.
Palliative & Supportive Care|June 27, 2014
Assessing cancer caregivers' needs for an early targeted psychosocial support project: The experience of the oncology department of the Poliambulanza FoundationFausto Meriggi, Federica Andreis, Veronica Premi, et al.
European Journal of Pharmacology|November 6, 2016
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparationsFederica Ferrari, Maria Camilla Cerlesi, Davide Malfacini, et al.
Clinical Genitourinary Cancer|January 19, 2016
Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter SurveyAlberto Diminutto, Umberto Basso, Marco Maruzzo, et al.
The Oncologist|October 16, 2016
Eribulin in Male Patients With Breast Cancer: The First Report of Clinical OutcomesFrancesco Giotta, Luigi Acito, Giampiero Candeloro, et al.
Pageof 8